Dermapharm Holding SE
Dermapharm Holding's Waste Data Preview
In 2023, Dermapharm Holding conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  a | 0000000 |
Total Waste Recovered | Copy/Paste is a PRO feature.  | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Hazardous Waste Generated | 0000000 | 0000000 | Copy/Paste is a PRO feature.  a | 0000000 |
Non-Hazardous Waste Disposed | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Verified Sources Behind Dermapharm Holding’s Waste Management Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dermapharm Holding’s data sources below and access millions more through our Disclosure Search.
Insights into Dermapharm Holding’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Dermapharm Holding generated a total of 8,033 metric tonnes of waste.a
Of this amount, 2.55% of Dermapharm Holding's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.97.46% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Dermapharm Holding’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Dermapharm Holding reduced the environmental impact of its waste?
Since 2019, Dermapharm Holding's total waste generation fell by 2.3%, but rose by 57.94% in 2023, potentially reflecting a temporary surge in activity or inconsistency in waste control strategies.a
Over the same period, Dermapharm Holding saw a long-term increase of 41.77% in hazardous waste share, but a 9.24% reduction in 2023, indicating a recent improvement that may reflect updated production inputs, enhanced treatment, or stricter controls.a
Overall, Dermapharm Holding's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a